184 related articles for article (PubMed ID: 25973737)
1. Increased Transforming Growth Factor-β Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy.
Ayça B; Sahin I; Kucuk SH; Akin F; Kafadar D; Avşar M; Avci II; Gungor B; Okuyan E; Dinckal MH
Clin Cardiol; 2015 Jun; 38(6):371-7. PubMed ID: 25973737
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Serum Omentin-1 Levels for the Prediction of Adverse Cardiac Events in Patients with Hypertrophic Cardiomyopathy.
Yıldız SS; Sahin I; Cetinkal G; Aksan G; Kucuk SH; Keskin K; Cetin S; Sigirci S; Avcı İİ; Kilci H; Kiliçkesmez K
Med Princ Pract; 2018; 27(2):107-114. PubMed ID: 29402833
[TBL] [Abstract][Full Text] [Related]
3. Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy.
Sahin I; Gungor B; Ozkaynak B; Uzun F; Küçük SH; Avci II; Ozal E; Ayça B; Cetın S; Okuyan E; Dinckal MH
Clin Cardiol; 2017 Jan; 40(1):32-37. PubMed ID: 27768229
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy.
Maron BJ; Tholakanahalli VN; Zenovich AG; Casey SA; Duprez D; Aeppli DM; Cohn JN
Circulation; 2004 Mar; 109(8):984-9. PubMed ID: 14967727
[TBL] [Abstract][Full Text] [Related]
5. Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
Panou FK; Kotseroglou VK; Lakoumentas JA; Chrysanthopoulou SA; Armeniakos JA; Stratigou T; Veve H; Zacharoulis AA
Hellenic J Cardiol; 2006; 47(6):344-51. PubMed ID: 17243506
[TBL] [Abstract][Full Text] [Related]
6. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
[TBL] [Abstract][Full Text] [Related]
7. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
Tesic M; Seferovic J; Trifunovic D; Djordjevic-Dikic A; Giga V; Jovanovic I; Petrovic O; Marinkovic J; Stankovic S; Stepanovic J; Ristic A; Petrovic M; Mujovic N; Vujisic-Tesic B; Beleslin B; Vukcevic V; Stankovic G; Seferovic P
J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide and outcome in patients with apical hypertrophic cardiomyopathy.
Shirotani S; Minami Y; Saito C; Haruki S; Hagiwara N
J Cardiol; 2020 Oct; 76(4):357-363. PubMed ID: 32439341
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy.
Minami Y; Haruki S; Kanbayashi K; Maeda R; Itani R; Hagiwara N
Heart Rhythm; 2018 Oct; 15(10):1484-1490. PubMed ID: 29709578
[TBL] [Abstract][Full Text] [Related]
11. Combined measurements of cardiac troponin I and brain natriuretic peptide are useful for predicting adverse outcomes in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Baba Y; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
Circ J; 2011; 75(4):919-26. PubMed ID: 21304210
[TBL] [Abstract][Full Text] [Related]
12. Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy.
Aizawa Y; Tanimoto Y; Hirata Y; Fujisawa T; Fukuoka R; Nakajima K; Katsumata Y; Nishiyama T; Kimura T; Yuasa S; Kohno T; Kohsaka S; Murata M; Maekawa Y; Furukawa Y; Takatsuki S; Fukuda K
Keio J Med; 2019 Dec; 68(4):87-94. PubMed ID: 30606897
[TBL] [Abstract][Full Text] [Related]
13. Interrelationship between the Myocardial Mass, Fibrosis, BNP, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
Miyaji Y; Iwanaga Y; Nakamura T; Yasuda M; Kawamura T; Miyazaki S
Intern Med; 2016; 55(10):1261-8. PubMed ID: 27181530
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
[TBL] [Abstract][Full Text] [Related]
15. Neurohumoral profiles in patients with hypertrophic cardiomyopathy: differences to hypertensive left ventricular hypertrophy.
Ogino K; Ogura K; Kinugawa T; Osaki S; Kato M; Furuse Y; Kinugasa Y; Tomikura Y; Igawa O; Hisatome I; Shigemasa C
Circ J; 2004 May; 68(5):444-50. PubMed ID: 15118286
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy.
Nakamura T; Sakamoto K; Yamano T; Kikkawa M; Zen K; Hikosaka T; Kubota T; Azuma A; Nishimura T
J Am Coll Cardiol; 2002 May; 39(10):1657-63. PubMed ID: 12020494
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy.
Kaski JP; Tomé-Esteban MT; Mead-Regan S; Pantazis A; Marek J; Deanfield JE; McKenna WJ; Elliott PM
Heart; 2008 Oct; 94(10):1307-11. PubMed ID: 18070943
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.
Wang Y; Gao W; Han X; Jiang J; Sandler B; Li X; Zema C
J Med Econ; 2023; 26(1):1495-1506. PubMed ID: 37902966
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of various "classic" echocardiographic and laboratory indices in distinguishing the "gray zone" between athlete's heart and hypertrophic cardiomyopathy: a pilot study.
Pagourelias ED; Efthimiadis GK; Kouidi E; Zorou P; Giannoglou G; Deligiannis A; Athyros VG; Karagiannis A; Geleris P
Echocardiography; 2013 Feb; 30(2):131-9. PubMed ID: 23167844
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy].
Faludi R; Tóth L; Pótó L; Cziráki A; Simor T; Papp L
Orv Hetil; 2005 Jan; 146(1):23-6. PubMed ID: 15715369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
